🇺🇸 FDA

Intelligence · INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 80 of 200 · A–Z by INN

  1. fosamprenavir calcium

    FOSAMPRENAVIR CALCIUM

    ORAL FDA: approved

  2. fosaprepitant

    FOSAPREPITANT MEDSURGE Lacuna Pharma Pty Ltd

    EMA: approved · TGA: approved

    A04AD12

  3. fosaprepitant dimeglumine

    FOSAPREPITANT DIMEGLUMINE Teva Pharma GmbH

    UNKNOWN FDA: approved

  4. fosaprepitant meglumine

    PROEMEND

    PMDA: approved

  5. foscarbidopa

    VYALEV

    SUBCUTANEOUS FDA: approved

  6. foscarnet sodium

    FOSCARNET SODIUM Amneal Pharma Europe Ltd

    INTRAVENOUS FDA: approved

  7. fosdenopterin

    NULIBRY

    EMA: approved

    A16AX19

  8. fosdenopterin hydrobromide

    NULIBRY

    INTRAVENOUS FDA: approved

  9. fosfomycin disodium

    CONTEPO

    INTRAVENOUS FDA: approved

  10. fosfomycin tromethamine

    FOSFOMYCIN TROMETHAMINE Amneal Pharma Europe Ltd

    ORAL FDA: approved

  11. fosinopril

    MONACE 10 Alphapharm Pty Ltd

    TGA: approved

  12. fosinopril sodium

    FOSINOPRIL SODIUM Teva Pharma GmbH

    ORAL FDA: approved

  13. fosmanogepix

    NMPA: clinical trials

  14. fosnetupitant + palonosetron

    AKYNZEO IV Lacuna Pharma Pty Ltd

    TGA: approved

  15. fosnetupitant chloride hydrochloride

    AKYNZEO

    INTRAVENOUS FDA: approved

  16. fosphenytoin sodium

    CEREBYX Regeneron Ireland Designated Activity Company (DAC)

    INJECTION FDA: approved

  17. fospropofol

    NMPA: clinical trials

  18. fospropofol disodium

    LUSEDRA

    INTRAVENOUS FDA: approved

  19. fostamatinib

    TAVLESSE

    EMA: approved

    B02BX

  20. fostamatinib disodium

    TAVALISSE RIGEL PHARMACEUTICALS INC

    ORAL FDA: approved

  21. fostemsavir

    RUKOBIA

    EMA: approved

    J05AX

  22. fostemsavir tromethamine

    RUKOBIA

    ORAL FDA: approved

  23. framycetin sulfate

    SOFRAMYCIN Lacuna Pharma Pty Ltd

    TGA: approved

  24. framycetin sulfate + gramicidin + dexamethasone

    OTODEX Lacuna Pharma Pty Ltd

    TGA: approved

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources